Tamper-Resistant Oxycodone Misused Less Often in Australia

This article originally appeared here.
Share this content:
Tamper-Resistant Oxycodone Misused Less Often in Australia
Tamper-Resistant Oxycodone Misused Less Often in Australia

FRIDAY, Jan. 12, 2018 (HealthDay News) -- The tamper-resistant formulation of controlled-release oxycodone in Australia reduced tampering among high-risk populations, according to a study published online Jan. 10 in The Lancet Psychiatry.

Briony Larance, Ph.D., from the University of New South Wales in Sydney, and colleagues assessed multiple data sources, including an interrupted time-series analyses of opioid sales data and multiple routinely collected health datasets; followed a cohort of people who previously tampered with pharmaceutical opioids; and analyzed annual surveys of injection drug users.

The researchers observed reduced sales of higher strengths of controlled-release oxycodone and increased sales of other oxycodone formulations. Across sentinel populations (e.g., prospective cohort, surveys of people who inject drugs, and clients of supervised injecting facilities or needle and syringe programs), meta-analyses showed reduced tampering of controlled-release oxycodone use (mainly injection), with no evidence of switching to heroin or other drug use. No significant effect was seen on population-level indicators of opioid overdose or numbers of patients seeking help or treatment.

"This formulation of controlled-release oxycodone reduced tampering with pharmaceutical opioids among people who inject drugs, but did not affect population-level opioid use or harm," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Jury Awards 4.62B in Johnson  Johnson Talcum Powder Lawsuit

Jury Awards $4.62B in Johnson & Johnson Talcum ...

The award includes $550 million in compensatory damages and $4.14 billion in punitive damages

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

Thirty people have been hospitalized, but no deaths have been reported

Data Support FDA Restrictions on Child Cough and Cold Medicines

Data Support FDA Restrictions on Child Cough and ...

Surveillance data showed more adverse events for children exposed to hydrocodone than codeine

is free, fast, and customized just for you!




Already a member?

Sign In Now »